NeuroBionics

NeuroBionics is developing minimally invasive neuromodulation therapy using bioelectric fibers delivered through blood vessels. Their technology aims to treat neurological conditions like depression, epilepsy, and Parkinson's disease, offering a less invasive alternative to traditional deep brain stimulation. The company's unique value proposition lies in its use of carbon nanotubes for longer-lasting, safer, and MRI-compatible electrodes.

Buy Funded Startups lists

Funding Round: Seed

Funding Amount: $5M

Date: 16-Jan-2025

Investors: Dolby Family Ventures, Future Ventures, GreyMatter Capital

Markets: Biotechnology, MedTech, Neurotechnology, Other Devices and Supplies, Other Healthcare Technology Systems, Therapeutic Devices

HQ: Somerville, Massachusetts, United States

Founded: 2023

Website: https://neurobionics.io/

LinkedIn: https://www.linkedin.com/company/neurobionics

Twitter:

Instagram: